Bharat Book

Report On Medical Imaging Markets: Molecular Imaging

Press Release   •   Oct 05, 2012 11:37 IST

Molecular imaging techniques include nuclear medicine imaging – positron emission tomography (PET) and single photon emission computed tomography (SPECT) and combination PET/CT and SPECT/CT techniques – as well as ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) imaging that are used with molecular imaging agents. http://www.bharatbook.com/medical-devices-market-research-reports/medical-imaging-markets-molecular-imaging.html
 
 Molecular imaging has evolved into a pillar of molecular medicine. It combines functional imaging with structural imaging so that specific in-vivo molecular processes can be identified and spatially pinpointed, often with the use of imaging contrast agents that bind to specific biological proteins. Molecular imaging is undertaking diagnostic and treatment roles as it enables physicians to pinpoint the locations of disease and track the progress of therapies. The same contrast agents used to highlight disease sites may even be able to carry drugs that can be selectively unleashed precisely where they are needed.
 
 Medical Imaging Markets: Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the following technologies:  Business Report
 
 PET
 SPECT-Gamma Camera Systems
 MRI
 CT
 Ultrasound
 SPECT/CT
 PET/CT
 
 For each of these modalities, the report provides current market size based on revenues to manufacturers of imaging systems used for molecular procedures, as well as forecasts of future revenues.
 
 Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis, and serious market watchers in medical imaging industries, as well as those serving or investing in medical imaging companies, will want to keep abreast of this new market. As part of its comprehensive coverage, Medical Imaging Markets: Molecular Imaging includes:
 
 Overview and Explanation of modalities and key applications
 Over 34 Figures and Tables to make market data accessible to users
 Review of Imaging Agents in Clinical Trials, or that are recently introduced
 Market Size and Forecasts are developed through 2014
 Profiles of Top Competitors in the industry
 Breakout of Regional Markets for Molecular Imaging – including BRIC markets
 Kalorama looks at the technologies currently used in molecular imaging but also examines novel research areas, such as: Diagnosing Fever of Unknown Origin
 Determine Malignancy in Potential Ovarian Cancer
 PET/CT Impacts Brain Tumor Management
 Improving Care for Neuroendocrine Cancer
 PET Optimizes Virtual Colonoscopy
 Staging Prostate Cancer
 Cyclotron Expansion
 Breast Cancer Screening
 PET Indicates Therapy Effectiveness
 Lower Dosage in Hybrid Imaging
 Analyze Differences in Biochemical Status of Tissues
 Myocardial Flow Reserve Analysis
 
 Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data provide multiple year forecasts for different product segments covered in the report. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians and researchers.
 
 The general aging of the population continues to build the need for diagnosticimaging services. While the aging population is one trend likely to affect imagingprocedure volumes, the behavioral and lifestyle trends of the world population are alsolikely to increase the need for imaging procedures. One example involves obesity, which is often linked to increased risks of cardiovascular disease, diabetes, hypertension, and other illnesses. Imaging is well suited to the diagnosis and management of many age-related diseases such as cardiovascular, cancer, inflammatory and neurological diseases. These diseases are becoming increasingly prevalent as the percentage of elderly people in the population rises. In the US, cancer and cardiovascular disease kill nearly 2 million people each year. According to the American Heart Association
 
 1.0 EXECUTIVE SUMMARY
 
1.1 Molecular Basis of Cell Function
 1.1.1 Personalized Medicine
 1.2 Driving Health Care
 1.3 Multicapabilities
 1.4 The Power of Imaging
 1.4.1 Key Modalities
 1.5 World Market Summary
 1.5.1 Market Drivers and Challenges
 1.5.2 Growth Analysis
 1.6 Methodology
 2.0 INTRODUCTION
 2.1 Definition
 2.1.1 Visualizing Biological Events
 2.1.2 For Diagnosis and More
 2.1.3 Molecular Agents
 2.2 New Direction for Medicine
 2.3 Modalities and Applications
 2.3.1 Nuclear Medicine
 2.3.1.1 PET
 2.3.1.1.1 Understanding Disease Mechanisms
 2.3.1.2 SPECT and Gamma Cameras
 2.3.3 MRI
 2.3.4 Ultrasound
 2.3.5 Fusion Imaging
 2.3.5.1 Dual-Modality Advantages
 2.3.5.2 PET/CT
 2.3.5.3 SPECT/CT
 2.3.5.4 PET/MRI
 2.3.5.4.1 Therapeutic Successes
 
 For more information kindly visit :
 
Medical Imaging Markets: Molecular Imaging
 
 Or
 
 Bharat Book Bureau
 Ph.: + 91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/#!/Sandhya3B
  http://bharatbookblog.wordpress.com/ 

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.